Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:adalimumab
|
| gptkbp:approvalYear |
2023
|
| gptkbp:ATCCode |
L04AB04
|
| gptkbp:biosimilar |
gptkb:Humira
|
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
YUSIMRY
|
| gptkbp:indication |
gptkb:juvenile_idiopathic_arthritis
gptkb:Crohn's_disease gptkb:psoriatic_arthritis ulcerative colitis rheumatoid arthritis ankylosing spondylitis plaque psoriasis |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Coherus_BioSciences
|
| gptkbp:powers |
40 mg/0.8 mL
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:bfsParent |
gptkb:Coherus_BioSciences
|
| gptkbp:bfsLayer |
7
|